BioCloner Health begins cooperation with the Pomeranian Science and Technology Park Gdynia (PPNT Gdynia)
We are pleased to announce the beginning of our partnership with the Pomeranian Science and Technology Park Gdynia (PPNT Gdynia) – one of the leading centers supporting the development of innovation in Poland. This partnership opens up new opportunities for us in the fields of biotechnology, regenerative medicine, and the implementation of advanced 3D bioprinting solutions.
The starting point of our collaboration with PPNT Gdynia was a joint project carried out in their 3D Printing Lab, which marked a new chapter in the development of our technologies. By using the Park’s advanced technical infrastructure, we were able to test our materials and solutions in an environment that meets medical requirements. This project was a significant step forward in the further development of 3D bioprinting and its practical applications in healthcare.
Since 2016, BioCloner Health has been developing original 3D bioprinting technology, which allows for the creation of three-dimensional structures using biomaterials and bioinks in sterile conditions. Our solutions support disease research, drug therapy testing, and the development of organ models and synthetic meniscus structures, reducing the need for animal testing. In these efforts, the support of the Pomeranian Science and Technology Park Gdynia has been invaluable. Their 3D Printing Lab offers unique technological capabilities, enabling the production of prints using materials intended for medical applications. The Park actively supports the development of innovative companies and technologies in the field of modern medicine.
The joint efforts of BioCloner Health and PPNT Gdynia could contribute to the creation of groundbreaking solutions in various fields of science.